Background {#Sec1}
==========

Conventional petroleum-based methods for the production of valuable chemicals are associated with several challenges, such as environmental concerns and limited availability of fossil fuel. Hence, various bio-based production methods using renewable feedstocks have recently been developed \[[@CR1], [@CR2]\]. To address the growing demand for the production of value-added products, such as platform chemicals and biopolymers from renewable resources, several engineered microorganisms have been developed \[[@CR3]--[@CR9]\].

Gamma aminobutyric acid (GABA), a non-protein amino acid, is widely expressed in prokaryotic and eukaryotic organisms \[[@CR10]\]. GABA is the primary inhibitory neurotransmitter in the nervous system of mammals. Generally, GABA is used in pharmaceuticals or food additives for its physiological functions \[[@CR11]--[@CR14]\]. Additionally, GABA has applications in the bio-based chemical and polymer industries, where GABA is used as the precursor of 2-pyrrolidone, which can be used as a solvent or as a monomer for the synthesis of nylon 4 \[[@CR15], [@CR16]\].

Several studies have reported the microbial production of GABA through proton-consuming decarboxylation of [l]{.smallcaps}-glutamate using two biological processes: whole-cell bioconversion or direct fermentation. GABA is mainly produced through whole-cell bioconversion of MSG or [l]{.smallcaps}-glutamate to GABA by heterologous expression of glutamate decarboxylase (GAD) in the host strain \[[@CR15], [@CR17]--[@CR24]\]. Additionally, several metabolically engineered microorganisms, such as *Corynebacterium glutamicum* and *Escherichia coli* have been developed for the direct fermentative production of GABA from renewable resources, such as glucose and xylose \[[@CR25]--[@CR31]\]. However, there are still several limitations associated with the efficient microbial fermentative production of GABA. For example, the optimal pH for GAD activity is around 4.5, though generally fermentation process of various industrial microorganisms such as *E. coli*, *C. glutamicum,* and *Lactobacillus* is performed around pH 7. These limitations could be addressed by developing GAD able to efficiently convert glutamate into GABA at pH 7 or by developing host strains that supports the enhanced cell robustness under acidic stress for facilitation of the GAD activity. In this regards, the recombinant *C. glutamicum* strain expressing GAD that is active at a wide pH range was reported to produce 38.6 g/L GABA in 72 h fed-batch fermentation from glucose \[[@CR32]\]. However, other strategy such as increasing cell tolerance to acidic stress for acidic fermentative production of GABA is but not yet developed.

*Deinococcus radiodurans* is reported to be resistant to various abiotic stress factors, such as γ-radiation, oxidizing agents, and desiccation \[[@CR33]\]. Recently, DR1558, a response regulator in the two-component signal transduction system, was identified in *D. radiodurans*. The expression of DR1558, which exhibits a *recA*-like expression pattern, was reported to be enhanced (approximately 5.64-fold) in response to 15 kGy of gamma radiation \[[@CR34]\]. DR1558 is reported to induce alterations in the cell by directly binding to the promoter regions of genes via DNA-binding domains or by binding to the effector molecules in response to environmental stress. One study has employed DR1558 for increasing the tolerance of *E. coli* against low pH, heat, and salt stresses \[[@CR35]\]. Additionally, DR1558 has been used to enhance cell robustness and production of succinate, 2,3-butanediol (2,3-BDO) and poly(3-hydroxybutyrate) \[P(3HB)\] in the recombinant *E. coli* strains \[[@CR36]--[@CR38]\].

In this study, the effect of *D. radiodurans* DR1558 on GABA production was examined in the recombinant *E. coli* strains under low pH culture conditions using two different strategies: whole-cell bioconversion of MSG to GABA and direct fermentative production of GABA from glucose. The quantitative real-time polymerase chain reaction (qRT-PCR) analysis was performed to evaluate the expression level of genes related to central metabolism and acid resistance (AR) under acidic challenge in the *dr1558*-overexpressing *E. coli* strains. Furthermore, fed-batch fermentation was carried out for direct fermentative production of GABA from glucose as a proof-of-concept and demonstrated that DR1558 can be robustly used in the fermentation scale.

Results and discussion {#Sec2}
======================

Examination of DR1558 expression for the acid-resistant conversion of MSG into GABA at low pH {#Sec3}
---------------------------------------------------------------------------------------------

The optimal pH for GAD, which catalyzes the conversion of glutamate into GABA, is around 4.5. This pH is lower than the neutral pH generally used for cell cultivation \[[@CR39], [@CR40]\]. Thus, we hypothesized that enhancing *E. coli* resistance to low pH may have a positive effect on GABA production as GABA can be produced at the pH optimum for the decarboxylation activity of GAD. To investigate the effect of DR1558 on GABA production, the recombinant *E. coli* WGB100 strain expressing GadBC and DR1558 and *E. coli* BL21(DE3) strain expressing only GadBC were cultured in the MR medium (pH 7.0) supplemented with 20 g/L glucose and 5 g/L yeast extract. When the optical density at 600 nm (OD~600~) of the culture reached 1.0, isopropyl-β-thiogalactoside (IPTG; final concentration, 0.5 mM) was added to the culture medium to induce protein expression. The cells were cultured for 8 h and transferred to the MR medium (pH 4.5) supplemented with 20 g/L glucose, 5 g/L yeast extract, and 13 g/L MSG·H~2~O. The *E. coli* BL21(DE3) strain expressing only GadBC exhibited a low conversion yield (41%; conversion of 13 g/L MSG·H~2~O into 2.97 g/L GABA) (Fig. [1](#Fig1){ref-type="fig"}b). However, the *E. coli* WGB100 strain expressing GadBC and DR1558 exhibited a high GABA yield (87.3%; conversion of 13 g/L MSG·H~2~O into 6.31 g/L GABA) within 24 h. Incubating the *E. coli* WGB100 strain till 60 h resulted in the production of 6.52 g/L GABA corresponding to a 90% yield (Fig. [1](#Fig1){ref-type="fig"}a). In previous report, the productivity of 0.12 g GABA/L/h was obtained by recombinant *E. coli* equipped with the C-terminus synthetic complex of GadB and GadC (pH3BN) \[[@CR41]\]. Additional expression of DR1558 along with the C-terminus synthetic complex of GadB and GadC in the engineered *E. coli* WGB100 in this study allowed the increased productivity of 0.26 g GABA/L/h \[[@CR41]\].Fig. 1Time profile of growth and production of gamma aminobutyric acid (GABA), monosodium glutamate (MSG), and metabolites in the whole-cell reaction by **a***Escherichia coli* WGB100 strain expressing GadBC and DR1558 and **b***E. coli* BL21(DE3) expressing only GadBC. The strains were cultivated in 50 mL MR medium supplemented with 5 g/L yeast extract, 20 g/L glucose, and 13 g/L MSG·H~2~O in a baffled flask at 30 °C. The data are represented as mean ± standard deviation from three independent experiments

Transcriptional analysis of genes involved in central metabolism and glutamate acid-dependent acid resistance (GDAR) system in *E. coli* {#Sec4}
----------------------------------------------------------------------------------------------------------------------------------------

The qRT-PCR analysis was performed to analyze the expression patterns of 37 genes associated with the central carbon metabolism, AR system, and respiratory chain complexes in the *E. coli* WGB100 and control strains as summarized in Fig. [2](#Fig2){ref-type="fig"} and Additional file [1](#MOESM1){ref-type="media"}: Table S2.Fig. 2Relative expression of genes related to acid resistance under mild acid stress conditions in *dr1558*-overexpressing *Escherichia coli*. **a** Glutamate-dependent acid resistance (GDAR) system; **b** components of the respiratory chain complexes. Each expression level was converted to the log base 2 of the value. For all genes represented in this figure, the *P*-value was \< 0.05 except for *ybaS*, *gadW*, and *gadX*. Histogram shows the mean of three biological replicates and error bars represent standard deviation

When the pH was decreased, the expression levels of genes involved in the central metabolic pathways, such as glycolysis and tricarboxylic acid (TCA) cycle in the *E. coli* WGB100 strain were upregulated when compared to those in the control strain (Additional file [1](#MOESM1){ref-type="media"}: Table S2). The expression levels of *ptsG* and *pykA*, which are associated with the glycolytic pathway, in the *E. coli* WGB100 strain were upregulated by 2.1-, and 1.76-fold, respectively, when compared to the control strain. This indicated enhanced glucose uptake by the *E. coli* WGB100 strain. As shown in Fig. [1](#Fig1){ref-type="fig"}, although the production of acetate in the recombinant *E. coli* WGB100 strain expressing both GadBC and DR1558 was similar to that of the control strain, the glucose consumption increased by 1.51-fold. This suggested that the carbon flux towards acetate metabolism in the *E. coli* WGB100 strain decreased based on the production of acetate relative to the consumption of carbon source. The expression of the *poxB* gene, which is involved in acetate metabolism, was downregulated by 3.67-fold in the *E. coli* WGB100 strain when compared to its expression in the control strain (Additional file [1](#MOESM1){ref-type="media"}: Table S2). The downregulation of acetate metabolism was also observed in our previous study in the *dr1558*-overexpressing *E. coli* for the production of 2,3-BDO and P(3HB) \[[@CR37], [@CR38]\].

Under low pH conditions, *E. coli* can maintain the pH homeostasis of the intracellular environment via carboxylation of amino acid by the proton-consuming AR system \[[@CR42], [@CR43]\]. *E. coli* contains four different amino acid-dependent AR systems: GDAR, arginine-dependent acid resistance system (ADAR), lysine-dependent acid resistance system (LDAR), and ornithine-dependent acid resistance system (ODAR). Among these four systems, the GDAR system comprising GadA, GadB, and GadC is associated with low pH tolerance in the *dr1558*-overexpressing *E. coli* \[[@CR35], [@CR44]--[@CR48]\]. Hence, the expression pattern of genes involved in the GDAR system was examined. The expression levels of *gadA*, *gadB*, and *gadC* genes in the *E. coli* WGB100 strain were upregulated by 2.19-, 1.13-, and 1.58-fold when compared to those in the control strain, respectively (Fig. [2](#Fig2){ref-type="fig"}b). Moreover, the mRNA levels of the *rpoS* and *gadE* genes, which indirectly affect the GDAR system, were also examined (Additional file [1](#MOESM1){ref-type="media"}: Table S2 and Fig. [2](#Fig2){ref-type="fig"}b). The proteins encoded by these genes, especially GadE, are involved in transcriptional regulation. GadE is the main regulator of the GDAR system and other acid fitness islands (AFIs), while RpoS is a sigma factor that simulates GadE expression \[[@CR49], [@CR50]\]. The transcriptional analysis revealed upregulated expression levels of *rpoS* and *gadE* genes, which subsequently increased the expression level of GDAR system.

Along with the GDAR system, various respiratory chain complexes, such as cytochrome *b*~*0*~ oxidase (Cyo), succinate dehydrogenase (SDH), and NADH dehydrogenase I (Nuo) that pump protons out of the cell are activated in *E. coli* as a metabolic response to acidic stress \[[@CR43]\]. Cyo exports cytoplasmic protons by converting molecular oxygen to H~2~O to generate the proton motive force (PMF) during aerobic growth under acidic conditions. Additionally, Nuo catalyzes the oxidation of NADH to NAD, which contributes to PMF by directly pumping out the protons \[[@CR47], [@CR51]\]. Hence, we also examined the expression level of genes associated with respiratory chain complexes. The expression levels of *nuoMN* and *cyoABCD* in the *dr1558*-overexpressing strain were 1.5-fold higher than those in the control strain (Fig. [2](#Fig2){ref-type="fig"}a). Thus, overexpression of DR1558 resulted in enhanced expression of GDAR system as well as the respiratory chain complexes, which improved cell viability of *E. coli* WGB100 by conferring acid resistance during the conversion of MSG to GABA at low pH culture conditions.

Reconstruction of GABA production pathway for the direct production of GABA from glucose {#Sec5}
----------------------------------------------------------------------------------------

The *E. coli* WGB100 strain can convert MSG into GABA while consuming glucose at pH 4.5. Hence, we hypothesized that GABA could be produced directly from glucose at low pH culture conditions via production of glutamate, a direct precursor of GABA (Fig. [1](#Fig1){ref-type="fig"}). Therefore, we constructed the metabolic pathway for direct synthesis of GABA from glucose. In a previous study, enhanced expression of *icdA* encoding isocitrate dehydrogenase and *gdhA* encoding glutamate dehydrogenase was reported to enhance the production of [l]{.smallcaps}-glutamate in the engineered *E. coli* \[[@CR52]\]. Thus, the two *E. coli* BL21(DE3)-derived mutant strains, *E. coli* DGB201 (BL21(DE3) *∆gabT* expressing GdhA and, GadBC) and *E. coli* DGB202 (BL21(DE3) *∆gabT* expressing IcdA, GdhA and, GadBC), were investigated for the production of GABA from glucose (Table [1](#Tab1){ref-type="table"}). The initial pH in the culture medium was set to 7.0 and the pH was not adjusted during the cultivation. After the formation of various organic acids, such as acetate and lactate, resulted in decreasing the pH in the culture medium, GABA was produced from glucose by the *E. coli* DGB201 and DGB202 strains (Additional file [1](#MOESM1){ref-type="media"}: Figure S1). However, the *E. coli* DGB201 and DGB202 strains exhibited a low production of GABA (up to 0.19 and 0.4 g/L, respectively) from 30 g/L of glucose when they were cultured in the medium without additional inorganic nitrogen source at an initial pH of 7.0 (Fig. [3](#Fig3){ref-type="fig"}c). To produce GABA from glucose efficiently, the production of glutamate should be properly supported by the recombinant *E. coli* host strain. Previous studies have reported that the supplementation of inorganic nitrogen sources, such as ammonium sulfate, urea, and ammonium chloride in the culture medium improved the production of [l]{.smallcaps}-amino acid by the microbial host strain \[[@CR53]\]. Hence, ammonium sulfate was added to the culture medium containing 30 g/L glucose to examine its effect on the production of GABA. The cell growth and glucose consumption in both the *E. coli* DGB201 and DGB202 strains were not markedly affected with supplementation of ammonium sulfate at concentrations of up to 15 g/L (Fig. [3](#Fig3){ref-type="fig"}a, b). Interestingly, glutamate was not detected in any of the culture media and GABA production was proportional to the concentration of ammonium sulfate in the culture medium. The supplementation of 15 g/L ammonium sulfate resulted in the highest GABA concentrations of 1.7 and 1 g/L in the *E. coli* DGB202 and *E. coli* DGB201 strain, respectively (Fig. [3](#Fig3){ref-type="fig"}c).Table 1Plasmid, strain used in this studyPlasmids, strainsCharacteristicsOrigin/Ab^R^SourcePlasmid pACYCDuet-1P~T7~::MSCp15A/Cm^R^Novagen pH3BNP~tac~::*gadB*-SH3D, *gadC*-SH3LColE1/Amp^R^\[[@CR41]\] pGB100P~T7~::*dr1558*p15A/Cm^R^This study pGB101P~T7~::*gdhA*-T~T7~p15A/Cm^R^This study pGB102P~T7~::*icdA*, *gdhA*-T~T7~p15A/Cm^R^This study pGB103P~T7~::*dr1558*-P~T7~::*icdA*, *gdhA*-T~T7~p15A/Cm^R^This study pREDETP~BAD~::*gam*, *beta*, *alpha*, *recA*pSC101/Amp^R^Gene Bridges pMloxClox66-Cm-lox71 cassetteCo1E1/Amp^R^, Cm^R^\[[@CR54]\] pJW168Cre-recombinasepSC101/Amp^R^\[[@CR55]\]Strain BL21(DE3)*fhuA2 \[lon\] ompT gal (λ DE3)\[dcm\] ∆hsdS*NEB GB200BL21(DE3) *ΔgabT*This study GB300BL21(DE3) *ΔgabT, ΔsucA*This study WGB100BL21(DE3)/pGB100, pH3BNThis study WGB200GB200/pGB100, pH3BNThis study DGB101BL21(DE3)/pGB101, pH3BNThis study DGB102BL21(DE3)/pGB102, pH3BNThis study DGB201GB200/pGB101, pH3BNThis study DGB202GB200/pGB102, pH3BNThis study DGB203GB200/pGB103, pH3BNThis study DGB301GB300/pGB101, pH3BNThis study DGB302GB300/pGB102, pH3BNThis study DGB303GB300/pGB103, pH3BNThis studyFig. 3Effect of ammonium sulfate supplementation on cell growth, glucose consumption, and gamma aminobutyric acid (GABA) production. The *Escherichia coli* DGB201 and DGB202 strains were cultured in MR medium supplemented with 30 g/L glucose, 5 g/L yeast extract, and (0, 5, 10, or 15 g/L) ammonium sulfate. **a** Cell growth; **b** glucose consumption; **c** GABA production. Histogram shows the mean of three biological replicates and error bars represent standard deviation

Effect of DR1558 on direct production of GABA from recombinant *E. coli* {#Sec6}
------------------------------------------------------------------------

The effect of DR1558 on the production of GABA was examined in the *E. coli* DGB203 (BL21(DE3) *∆gabT* expressing IcdA, GdhA, GadBC, and DR1558) strain. The *E. coli* DGB202 (BL21(DE3) *∆gabT* expressing IcdA, GdhA, and GadBC) strain was used as a control. Both *E. coli* strains were cultured in the MR medium supplemented with 30 g/L glucose, 5 g/L yeast extract, and 15 g/L ammonium sulfate at an initial pH of 7.0 for 24 h. When the cultures reached an OD~600~ of 0.5, 0.5 mM IPTG was added to induce the GABA production pathway.

The *E. coli* DGB203 strain exhibited a higher glucose consumption than the *E. coli* DGB202 strain (Fig. [4](#Fig4){ref-type="fig"}b). The final cell density of the *E. coli* DGB202 strain was higher than that of the *E. coli* DGB203 strain (Fig. [4](#Fig4){ref-type="fig"}a). Although glutamate was not detected in both *E. coli* DGB202 and DGB203 strains during cultivation, the titer and yield of GABA production in the *E. coli* DGB203 strain increased from 1.6 to 2.8 g/L and 0.059 to 0.093 (g~GABA~/g~Glucose~), respectively, when compared to those in the *E. coli* DGB202 strain (Fig. [4](#Fig4){ref-type="fig"}c, d).Fig. 4Effect of DR1558 on cell growth, glucose consumption, glutamate production, and gamma aminobutyric acid (GABA) production in the recombinant *Escherichia coli*. The *E. coli* DGB202 and DGB203 strains were cultured in MR medium supplemented with 5 g/L yeast extract, 30 g/L glucose, and 15 g/L ammonium sulfate for 24 h. The *E. coli* DGB302 and DGB303 strains were cultured in MR medium supplemented with 5 g/L yeast extract, 20 g/L glucose, and 10 g/L ammonium sulfate for 48 h. **a** Cell growth; **b** glucose consumption; **c** glutamate production; **d** GABA production. Histogram shows the mean of three biological replicates and error bars represent standard deviation

As the yields of GABA obtained in both *E. coli* DGB202 and DGB203 strains were low, *sucA* encoding 2-oxoglutarate decarboxylase, which competes with *gdhA* encoding glutamate dehydrogenase in the GABA pathway, was deleted in the *E. coli* GB200 (BL21(DE3) *∆gabT*) strain. The GABA titer in the *E. coli* DGB303 (BL21(DE3) *∆gabT ∆sucA* expressing IcdA, GdhA, GadBC, and DR1558) strain slightly increased from 2.82 to 3.08 g/L when compared to that in the *E. coli* DGB203 strain. Additionally, the yield of GABA in the *E. coli* DGB303 strain significantly increased from 0.093 to 0.41 (g~GABA~/g~Glucose~), corresponding to a 4.41-fold increase, when compared to that in the *E. coli* DGB203 strain (Fig. [4](#Fig4){ref-type="fig"}d). However, the productivity of GABA production in the *E. coli* DGB303 strain decreased from 0.12 to 0.064 (g/L/h) when compared to that in the *E. coli* DGB203 strain. As *sucA* is an essential gene for *E. coli* cell growth, the final cell density of *E. coli* DGB303 was lower than that of *E. coli* DGB203. Therefore, *E. coli* DGB203 strain was selected for further experiments.

Interestingly, the *E. coli* DGB302 (BL21(DE3) *∆gabT ∆sucA* expressing IcdA, GdhA, and GadBC genes) strain failed to convert glutamate into GABA and secreted 1.13 g/L glutamate into the culture medium, whereas the *E. coli* DGB303 strain did not secrete glutamate into the culture medium (Fig. [4](#Fig4){ref-type="fig"}c, d).

Production of GABA from glucose in fed-batch culture {#Sec7}
----------------------------------------------------

To optimize the concentration of IPTG in the culture medium, different concentrations of IPTG (0.05, 0.1, 0.5, or 1 mM) were supplemented in the MR medium with a glucose/ammonium sulfate ratio of 2. The cell growth in the medium supplemented with 0.05 and 0.1 mM IPTG significantly decreased (from 23 to 16 of OD~600~) when compared to that in the medium supplemented with 0.5 mM IPTG. However, in all concentrations of IPTG except for 1 mM, the titer of GABA was increased by the addition of IPTG. The highest titer of GABA (2.79 g/L) was obtained in the medium supplemented with 0.5 mM IPTG (Fig. [5](#Fig5){ref-type="fig"}). Based on these results, the fed-batch culture of the *E. coli* DGB203 strain was performed in the MR medium with a glucose/ammonium sulfate ratio of 2 and 0.5 mM IPTG.Fig. 5Effect of isopropyl-β-thiogalactoside (IPTG) on cell growth, glucose consumption, and gamma aminobutyric acid (GABA) production. The *Escherichia coli* DGB203 strain was cultured in MR medium supplemented with 5 g/L yeast extract, 30 g/L glucose, and 15 g/L ammonium sulfate for 24 h. Histogram shows the mean of three biological replicates and error bars represent standard deviation

The cells were cultured till OD~600~ of 5 at pH 7.0 and IPTG was added to the culture medium at a final concentration of 0.5 mM to induce protein expression. The cells were further cultured for 5 h at pH 7.0 and then the pH was lowered to 5.0. GABA was initially not detected in the culture medium at pH 7.0 after induction. However, decreasing the pH to 5.0 and the addition of glucose enhanced the GABA production. The cell density reached an OD~600~ of 82 in 38 h. The titer of GABA reached 6.16 g/L after 38 h and the glucose consumption was 116.82 g/L. During fed-batch fermentation, glutamate and fermentative by-products, such as acetate and lactate were not detected in the culture medium (Fig. [6](#Fig6){ref-type="fig"}). These results indicated that DR1558 was beneficial for the carbon flux toward GABA production under acidic environmental conditions at the fermentation scale.Fig. 6The fermentation profile during the synthesis of gamma aminobutyric acid (GABA) from glucose by the *Escherichia coli* DGB203 strain in fed-batch culture. The black arrow represents induction timing for gene expression

Currently, there are several reports on direct fermentative production of GABA from glucose using engineered *E. coli*. The recombinant *E. coli* containing the synthetic scaffolds between *icdA*, *gltB*, and *gadB* produced 1.3 g/L of GABA from 10 g/L glucose in 48 h \[[@CR25]\]. Additionally, GABA production from glucose through GABA shunt in the recombinant *E. coli* was 1.08 g/L from 10 g/L glucose in 48 h \[[@CR30]\]. Recently, synthetic metabolic toggle switch, which controls the expression of multiple metabolic states, was introduced in *E. coli* to produce GABA from glucose, which resulted in the production of 4.8 g/L GABA from 20 g/L glucose \[[@CR56]\]. However, these GABA fermentation processes were performed in the shake flask scale. In this study, we demonstrated that introducing DR1558 in the GABA-producing *E. coli* provides robustness to cells against acid stress for fermentative scale production of GABA from glucose under acid culture conditions. Thus, this study provides an engineering strategy for GABA production from glucose in industrial processes under low pH condition.

Conclusions {#Sec8}
===========

In this study, we reported that DR1558 can enhance the production of GABA at low pH, optimal for GAD which had been a limiting factor for fermentative GABA production in the recombinant *E. coli*. We developed two different GABA production strategies: whole-cell bioconversion of GABA from MSG and direct fermentative production of GABA from glucose. Under low pH culture conditions, the *dr1558*-overexpressing *E. coli* exhibited enhanced cell growth rate and GABA production. Furthermore, the transcriptional analysis revealed that DR1558 enabled the growth of *E. coli* at pH 4.5 by increasing the expression levels of GDAR system and proton-pumping respiratory chain complexes. As the bioconversion of GABA from glutamate was observed with optimal cell viability under acidic conditions by the introduction of DR1558, fermentative production of GABA from glucose was also examined. The fermentative process enhanced the production of GABA with the expression of *dr1558* in *E. coli* (Fig. [7](#Fig7){ref-type="fig"}). To the best of our knowledge, this is the first study to report the acidic fermentation of GABA. This study provides an engineering strategy for conferring AR to *E. coli*, which can be used to produce GABA via the GAD system that functions at low pH.Fig. 7Metabolic engineering of *E. coli* for the production of gamma aminobutyric acid (GABA) using a response regulator. The blue line represents gene overexpression. The red X\'s represents knockout of genes

Methods {#Sec9}
=======

Bacterial strains and plasmids {#Sec10}
------------------------------

All bacterial strains, plasmids, and primers used in this study are listed in Table [1](#Tab1){ref-type="table"} and Additional file [1](#MOESM1){ref-type="media"}: Table S1. In this study, *E. coli* XL1-Blue (Stratagene Cloning Systems, La Jolla, CA, USA) was used for standard gene cloning. For the synthesis of GABA, *E. coli* BL21 (DE3) (New England Biolabs, Ipswich, MA, USA) and its mutants were used as host strains.

The *E. coli* GB200 (BL21(DE3) *ΔgabT*) and GB300 (BL21(DE3) *ΔgabT ΔsucA*) strains were constructed by deleting the corresponding genes in the chromosome of *E. coli* BL21(DE3) using the single-step gene knockout method as previously described \[[@CR57]\].

The construction of pH3BN plasmid expressing *N. crassa gadB* and *E. coli gadC*, which convert glutamate into GABA, was previously described \[[@CR41]\]. The pGB100 plasmid was constructed by inserting the *dr1558* gene, which was amplified by PCR using the dr1558-F and dr1558-R primers, from the genomic DNA of *D. radiodurans* into the pACYCDuet-1 (Novagen, Madison, WI, USA) plasmid at the NcoI and BamHI restriction sites.

The pGB101, pGB102, and pGB103 plasmids were constructed based on the pACYCDuet-1 plasmid to synthesize endogenous glutamate, a precursor of GABA, from glucose. The pGB101 plasmid was constructed by inserting the *E. coli gdhA* gene into the pACYCDuet-1 plasmid at the *Eco*RV and *Xho*I restriction sites. The pGB102 plasmid was constructed by inserting the *E. coli icdA* gene into the pGB101 plasmid at the NdeI and BglII restriction sites. Finally, the *dr1558* gene was inserted into the pGB102 plasmid at the NcoI and BamHI restriction sites to generate the pGB103 plasmid.

Culture condition for whole-cell bioconversion of glutamate to GABA {#Sec11}
-------------------------------------------------------------------

The *E. coli* WGB100 strain was used as a host strain for whole-cell bioconversion of glutamate to GABA. The seed cultures were cultivated at 30 °C in a 10-mL tube containing 3 mL Luria--Bertani (LB) medium (10 g/L tryptone, 5 g/L yeast extract, and 5 g/L NaCl) for 12 h at 250 rpm. For shake flask cultures, 3% (v/v) seed cultures were added to 50 mL MR medium supplemented with 20 g/L glucose and 5 g/L yeast extract. The composition of the MR medium (pH 7.0) was as follows: 6.67 g/L KH~2~PO~4~, 4 g/L (NH~4~)~2~HPO~4~, 0.8 g/L MgSO~4~·7H~2~O, 0.8 g/L citric acid, and 5 mL/L of trace metal solution. The composition of trace metal solution was as follows: 10 g/L FeSO~4~·7H~2~O, 2 g/L CaCl~2~, 2.2 g/L ZnSO~4~·7H~2~O, 0.5 g/L MnSO~4~·4H~2~O, 1 g/L CuSO~4~·5H~2~O, 0.1 g/L (NH~4~)~6~Mo~7~O~24~·4H~2~O, and 0.02 g/L Na~2~B~4~O~7~·10H~2~O prepared in 0.5 M HCl. MgSO~4~·7H~2~O was sterilized separately. Ampicillin (Ap, 100 μg/mL) and chloramphenicol (Cm, 35 μg/mL) were added to the medium depending on the antibiotic resistance marker of plasmids. When the OD~600~ of the culture reached 1.0, IPTG was added to the culture medium at a final concentration of 0.5 mM to induce protein expression. The cells were cultured for 8 h after IPTG induction. The recombinant *E. coli* strain was harvested by centrifugation at 8000*g* and 4 °C for 10 min. The cell pellet was washed with distilled water to remove the salts. The cells were then transferred to fresh MR (pH 4.5) medium supplemented with 20 g/L glucose, 5 g/L yeast extract, and 13 g/L MSG·H~2~O (Dae Jung Chemicals and Metals Co. Ltd., Siheung, Korea) for the production of GABA.

Culture condition for direct synthesis of GABA from glucose {#Sec12}
-----------------------------------------------------------

For the direct synthesis of GABA from glucose, the recombinant *E. coli* DGB201, DGB202, and DGB203 strains were cultured in MR medium (pH 7.0) supplemented with 30 g/L glucose, 5 g/L yeast extract, and 15 g/L ammonium sulfate at 30 °C for 24 h. The recombinant *E. coli* DGB302 and DGB303 strains were cultured in the MR medium (pH 7.0) supplemented with 20 g/L glucose, 5 g/L yeast extract, and 10 g/L ammonium sulfate at 30 °C for 48 h. Next, 35 μg/mL chloramphenicol and 100 μg/mL ampicillin were added to the culture medium. When the OD~600~ of the culture reached 0.5, IPTG was added to the culture medium at a final concentration of 0.5 mM.

The fed-batch culture was performed at 30 °C in a 5-L bioreactor (BioCNS, Daejeon, Korea) containing 1.8 L of MR medium supplemented with 5 g/L yeast extract, 20 g/L glucose, and 10 g/L ammonium sulfate. The seed culture (200 mL) was prepared in LB medium. When the OD~600~ of the culture reached 5, IPTG was added to the culture medium at a final concentration of 0.5 mM for inducing protein expression. The culture pH was adjusted using 5 M NaOH and 5 M HCl. The level of dissolved oxygen concentration (DOC) was maintained at 20% by automatically increasing the agitation speed to 1000 rpm and supplying pure oxygen. The feeding nutrition solutions were added to the culture medium when glucose levels depleted. The composition of the feeding nutrition was as follows: 500 g/L glucose, 500 g/L ammonium sulfate, 400 g/L yeast extract, 150 g/L MgSO~4~·7H~2~O. For the GABA production, the culture pH was adjusted to 5.0 using 5 M HCl when the initially supplied glucose levels depleted.

Analytical procedure {#Sec13}
--------------------

The cell growth was analyzed by measuring the optical density (OD~600~) using a UV spectrophotometer (Molecular Devices, San Jose, CA). To determine the GABA and glutamate contents, the cell supernatants were analyzed by high-performance liquid chromatography (HPLC, Agilent Technologies Inc., Santa Clara, CA) equipped with ZORBAX SB-C18 column (250 × 4.6 mm) (Agilent Technologies Inc., Santa Clara, CA) as described previously \[[@CR58]\]. The concentrations of organic acids and glucose were analyzed by HPLC equipped with Aminex HPX-76H column (300 × 7.8 mm) (Bio-Rad, Hercules, CA).

qRT-PCR {#Sec14}
-------

To investigate the changes in the gene expression pattern, the cells were cultured for 3 h after the pH was reduced to 4.5. The cells were then harvested by centrifugation at 10,000*g* and 4 °C for 5 min (Fig. [1](#Fig1){ref-type="fig"}). Total RNA was extracted using the RNA mini prep kit (Qiagen, Venlo, The Netherlands), following the manufacturer's instructions. The isolated RNA was reverse transcribed using the first-strand cDNA synthesis kit (TaKaRa Bio Inc., Kusatsu, Japan), following the manufacturer's instructions. The primers used in the qRT-PCR analysis are described in Additional file [1](#MOESM1){ref-type="media"}: Table S1. To analyze the transcriptional level, 20 ng of template cDNA and 10 pmol of each primer were added to the TB green premix Ex Taq (TaKaRa) in a Real-Time PCR system (Illumina Inc., San Diego, CA). The PCR conditions were as follows: 40 cycles of 95 °C for 10 s and at 58 °C for 30 s. The data were log~2~-transformed and normalized using 2^−ΔΔCt^ method for the analysis of the relative changes in gene expression. When using the 2^−ΔΔCt^ method, the transcriptional results are presented as the fold changes in gene expression normalized to the internal control and relative to the untreated control \[[@CR59]\]. The internal controls, used in qRT-PCR for the purpose of normalizing the PCRs, were *polA* and *dnaA*, which encode DNA polymerase I and dual-transcriptional regulator, respectively. Transcriptional analysis of *E. coli* WGB100 (pGB100 and pH3BN) as *dr1558* overexpressing strain and *E. coli* (pH3BN) as control strain was carried out to elucidate how DR1558 affects the metabolic pathway of host cell in GABA production. All experiments were performed in triplicates. The statistical significance of the observed differences in gene expression was evaluated by a student's *t*-test. Genes whose expression differed more than twofold were considered differentially expressed. Only changes with a threshold *P*-value of \< 0.05 were seen as statistically significant.
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 {#Sec15}

**Additional file 1: Table S1.** Primers used in this study. **Table S2.** Relative gene expression of *dr1558* overexpression strain. **Figure S1.** Time profile of GABA and pH in flask cultivation of recombinant *E. coli.* A) *E. coli* DGB201 strain expressing GdhA and GadBC genes.; B) *E. coli* DGB202 strain expressing IcdA, GdhA, and GadBC genes. Strains were cultivated in 50 mL MR medium supplied with 5 g/L Yeast Extract, 30 g/L glucose in a baffled flask at 30 °C for 24 h.

*aceA* (Icl)

:   Isocitrate lyase

*aceB* (MS)

:   Malate synthase

*aceE* (AceE)

:   Pyruvate dehydrogenase E1 component

*ackA* (AckA)

:   Acetate kinase

ACOA

:   Acetyl-CoA

*acs* (Acs)

:   Acetyl-CoA synthetase

*actP* (ActP)

:   Acetate permease

*crp* (Crp)

:   cAMP receptor protein

*cyoABCD* (CyoABCD)

:   Cytochrome *b*~*0*~ ubiquinol oxidase

*fruR* (FruR)

:   Catabolite repressor

G6P

:   Glucose 6-phosphate

*gadA* (GadA)

:   Glutamate decarboxylase A

*gadB* (GadB)

:   Glutamate decarboxylase B

*gadC* (GadC)

:   Glutamate/gamma-aminobutyrate antiporter

*gadE* (GadE)

:   DNA-binding transcriptional activator

*gadW* (GadW)

:   DNA-binding transcriptional dual regulator

*gadX* (GadX)

:   DNA-binding transcriptional dual regulator

*icdA* (IcdA)

:   Isocitrate dehydrogenase

*ihfA* (IHF α subunit)

:   Subunit of integration host factor

*mdh* (Mdh)

:   Malate dehydrogenase

*nuoMN* (NuoMN)

:   Subunit of NADH:quinone oxidoreductase I

OAA

:   Oxaloacetate

*pdhR* (PdhR)

:   Pyruvate dehydrogenase complex repressor

PEP

:   Phosphoenolpyruvate

*poxB* (PoxB)

:   Pyruvate oxidase

*pta* (Pta)

:   Phosphotransacetylase

*ptsG* (PtsG)

:   Subunit of enzyme IIglc

*pykA*, *pykF* (Pyk)

:   Pyruvate kinase

PYR

:   Pyruvate

*rpoD* (RpoD)

:   RNA polymerase sigma 70 subunit

*rpoS* (RpoS)

:   RNA polymerase sigma 38 subunit

*sdhC* (Sdh)

:   Succinate dehydrogenase

*sucA* (SucA)

:   2-oxoglutarate dehydrogenase E1 component

*ybaS* (YbaS)

:   Glutaminase A

*zwf* (Zwf)

:   Glucose 6-phosphate dehydrogenase

α-KG

:   Alpha ketoglutarate
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